gabexate has been researched along with Diarrhea in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Diarrhea: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kusunoki, Y | 1 |
| Nobumoto, K | 1 |
| Ohkawa, M | 1 |
| Watanabe, T | 1 |
| Hamada, I | 1 |
| Tochimaru, H | 1 |
1 trial available for gabexate and Diarrhea
| Article | Year |
|---|---|
Gabexate mesilate plus intravenous gammaglobulin treatment in children with diarrhoea-associated haemolytic uraemic syndrome.
Topics: Child; Child, Preschool; Diarrhea; Female; Gabexate; Hemolytic-Uremic Syndrome; Humans; Immunoglobul | 1998 |